000 01664 a2200421 4500
005 20250517170733.0
264 0 _c20181003
008 201810s 0 0 eng d
022 _a1931-8448
024 7 _a10.1089/mdr.2017.0048
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNachappa, Somanna Ajjamada
245 0 0 _aDetection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India.
_h[electronic resource]
260 _bMicrobial drug resistance (Larchmont, N.Y.)
_cMay 2018
300 _a377-385 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlleles
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aBacterial Proteins
_xgenetics
650 0 4 _aCatalytic Domain
_xdrug effects
650 0 4 _aDrug Resistance, Multiple, Bacterial
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIndia
650 0 4 _aIsoniazid
_xpharmacology
650 0 4 _aMicrobial Sensitivity Tests
_xmethods
650 0 4 _aMolecular Docking Simulation
_xmethods
650 0 4 _aMultiplex Polymerase Chain Reaction
_xmethods
650 0 4 _aMutation
_xdrug effects
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aRifampin
_xpharmacology
650 0 4 _aSequence Analysis, DNA
_xmethods
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
700 1 _aNeelambike, Sumana M
700 1 _aAmruthavalli, Chokkanna
700 1 _aRamachandra, Nallur B
773 0 _tMicrobial drug resistance (Larchmont, N.Y.)
_gvol. 24
_gno. 4
_gp. 377-385
856 4 0 _uhttps://doi.org/10.1089/mdr.2017.0048
_zAvailable from publisher's website
999 _c27470950
_d27470950